Mehmet Emin Kalender

Mehmet Emin Kalender

Auto-generated profile, based on publicly available information

Mehmet Emin Kalender

Department of Medical Oncology, Medical Faculty, Gaziantep University, Gaziantep Oncology Hospital, Gaziantep, Turkey

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2015 in Experimental Oncology
Verified
Journal Article
Closed access
YSY Sozucan
Y Sozucan
MKM E Kalender
M E Kalender
ISI Sari
I Sari
ASA Suner
A Suner
SOS Oztuzcu
S Oztuzcu
CCC Camci
C Camci
Colorectal cancer (CRC) is the most common cancer of the gastrointestinal tract. Different factors are responsible for the development of CRC. Transient Receptor Potential (TRP) which is an important component of calcium channel is associated with several pathological conditions like cancer, neurodegenerative and cardiovascular diseases. Thirty members of the family of TRP ion channel in mammals have been determined till now. The aim of this study is to investigate TRPM, TRPV and TRPC gene expression levels in tumor tissues of CRC patients and to analyze the relationship of expression in tumor tissue of CRC with other known prognostic factors. Material and Methods: In this study, 93 CRC patients were included. The level of TRP gene expression in paraffin blocks of normal and cancerous colorectal tissue samples were studied at the level of mRNA with Real-time PCR. Results: The mRNA expression level of TRPV3, TRPV4, TRPV5, TRPM4 and TRPC6 genes in 37 female and 56 male patients diagnosed with CRC was revealed lower in tumor tissue as compared to normal tissue (p < 0.05). No statistically significant differences of mRNA expression levels of other TRP genes were found. Conclusions: TRP gene family like TRPV3, TRPV4, TRPV5, TRPM4 and TRPC6 may be thought as potential genes contributing to tumorigenesis as their expression decreases in CRC as compared to normal tissues.

8 July 2008 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
MKMehmet Emin Kalender
Mehmet Emin Kalender
ASAlper Sevinc
Alper Sevinc
MYMustafa Yilmaz
Mustafa Yilmaz
COCoskun Ozsarac
Coskun Ozsarac
CCCelalettin Camci
Celalettin Camci

22 January 2013 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
IEIbrahim Erkutlu
Ibrahim Erkutlu
ACAhmet Cigiloglu
Ahmet Cigiloglu
MKMehmet Emin Kalender
Mehmet Emin Kalender
MAMehmet Alptekin
Mehmet Alptekin
ADA. Tuncay Demiryurek
A. Tuncay Demiryurek
CCCelalettin Camcı
Celalettin Camcı

1 January 2011
Verified
Journal Article
Closed access
ASAlper Sevinc
Alper Sevinc
MKMehmet Emin Kalender
Mehmet Emin Kalender
MAMustafa Altinbas
Mustafa Altinbas
MOMetin Ozkan
Metin Ozkan
MDMustafa Dikilitas
Mustafa Dikilitas
A(Anatolian Society Of Medical Oncology (Asmo)
Anatolian Society Of Medical Oncology (Asmo)

1 October 2011 in Clinical Nuclear Medicine
Verified
Journal Article
Closed access
EKEbuzer Kalender
Ebuzer Kalender
MYMustafa Yilmaz
Mustafa Yilmaz
SESuna Erkilic
Suna Erkilic
MYMehmet Yilmaz
Mehmet Yilmaz
ZCZeki Celen
Zeki Celen
Primary cutaneous diffuse large B-cell lymphoma is an uncommon type of non-Hodgkin lymphomas. A 51-year-old man had 2 gradually enlarging reddish, firm, and painless cutaneous-subcutaneous masses surrounded with some erythematous patches on his back for 3 years. Skin biopsy result was consistent with diffuse large B-cell lymphoma. FDG PET/CT was performed for staging and demonstrated bilaterally increased FDG uptake in the cutaneous masses with hypermetabolic left axillary lymph nodes. After chemotherapy, FDG PET/CT demonstrated that all FDG-avid lesions resolved, and there is a complete response to therapy.

13 August 2011
Verified
Journal Article
Closed access
ASAlper Sevinc
Alper Sevinc
MSMesut Seker
Mesut Seker
ABAhmet Bilici
Ahmet Bilici
NONuriye Yildirim Ozdemir
Nuriye Yildirim Ozdemir
RYRamazan Yildiz
Ramazan Yildiz
SBSuleyman Buyukberber
Suleyman Buyukberber